...
首页> 外文期刊>Molecular pharmacology. >Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor.
【24h】

Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor.

机译:尼古丁和神经生长因子对PC12细胞中烟碱型乙酰胆碱受体的差异调节。

获取原文
获取原文并翻译 | 示例
           

摘要

Neuronal nicotinic receptors in PC12 cells were measured by binding with [3H]epibatidine and in functional studies with agonist-stimulated 86Rb+ efflux and [3H]norepinephrine release assays. Two subtypes of receptors labeled by [3H]epibatidine were found: one that was increased about 4-fold in cells grown for 2 to 4 days in the presence of nicotine and one that was increased 5-fold in cells grown for 2 to 4 days in the presence of nerve growth factor (NGF). The actions of the two treatments were superadditive, resulting in approximately a 13-fold increase in binding sites in cells grown in the combination of the two treatments. The pharmacology of the binding sites in the nicotine- and NGF-treated cells was compared with the pharmacology of defined alpha3beta2 and alpha3beta4 nicotinic acetylcholine receptor (nAChR) subtypes heterologously expressed in human embryonic kidney 293 cells. Nicotine treatment predominantly increased a receptor with characteristics of an alpha3beta2 subtype, whereas the NGF treatment exclusively increased a receptor with characteristics of an alpha3beta4 subtype. Nicotinic receptor-mediated function measured with the 86Rb+ efflux assay was evident only in the NGF-treated cells, and it had a pharmacological profile that was, again, nearly identical to that of the heterologously expressed alpha3beta4 receptor subtype. Receptor function measured with the [3H]norepinephrine release assay was measurable in both nicotine-treated and NGF-treated cells; however, cytisine-stimulated [3H]norepinephrine release indicated that nicotine treatment increased an nAChR containing beta2 subunits, whereas NGF increased a receptor containing beta4 subunits. NGF treatment increased mRNA only for beta4 subunits in these cells, whereas nicotine treatment did not affect mRNA for any of the subunits measured. After withdrawal of the treatments, the receptors increased by nicotine were much less stable than those increased by NGF.
机译:PC12细胞中的神经元烟碱样受体是通过与[3H]依巴替丁结合并在激动剂刺激的86Rb +外排和[3H]去甲肾上腺素释放试验中进行功能测定的。发现了两种被[3H]表巴替丁标记的受体亚型:一种在尼古丁存在下生长2-4天的细胞中增加约4倍,另一种在生长2-4天的细胞中增加5倍。存在神经生长因子(NGF)。两种处理的作用是超加性的,导致两种处理组合生长的细胞中结合位点增加约13倍。将尼古丁和NGF处理的细胞中结合位点的药理学与在人类胚胎肾293细胞中异源表达的定义的α3β2和α3β4烟碱型乙酰胆碱受体(nAChR)亚型的药理学进行了比较。尼古丁治疗主要增加具有α3beta2亚型特征的受体,而NGF治疗仅增加具有α3beta4亚型特征的受体。仅在NGF处理的细胞中,用86Rb +外排测定法测量的烟碱受体介导的功能是明显的,并且其药理学特征与异源表达的alpha3beta4受体亚型几乎相同。用[3H]去甲肾上腺素释放测定法测量的受体功能在尼古丁处理过的细胞和NGF处理过的细胞中均可测量。然而,胱氨酸刺激的[3H]去甲肾上腺素释放表明尼古丁治疗增加了含有β2亚基的nAChR,而NGF增加了含有β4亚基的受体。 NGF处理仅增加了这些细胞中beta4亚基的mRNA,而尼古丁处理并未影响所测任何亚基的mRNA。停止治疗后,烟碱增加的受体比NGF增加的受体稳定得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号